Aci Cancer 9-06 Palo Alto

ACI’s Sixth National Conference on… September 18-20, 2006 • Palo Alto, CA

Adding, Updating and Expanding

COMPREHENSIVE CANCER PROGRAMS AND SERVICES For Hospitals and Health Systems

INCLUDES SITE TOUR OF THE STANFORD HOSPITAL AND CLINICS A National Oncology Conference Focused on Exploring The Latest Developments For Managing A More Competitive and Comprehensive Cancer Program to Increase Patient Volume, Improve Outcomes and Excel in Total Patient Cancer Care. Gain Knowledge From Experts on the Opportunities to Add and Expand Oncology Services to Better Detect, Diagnose and Treat Cancer. Explore Techniques to Better Equip Cancer Centers with the Latest Advancements in Medical Technology through Real Case Studies, Research Findings and Organizational Models from Renowned Cancer Institutes.

WHAT WILL BE DISCUSSED

DISTINGUISHED SPEAKING FACULTY INCLUDE

• Comprehensive Cancer Centers: Obstacles to a successful business model

Karyn A. Goodman, M.D., Assistant Professor, Department of Radiation Oncology, Stanford Cancer Center

• Improving the delivery of cancer patient care, through the streamlining and integration of medical programs, staff, and resources for more efficient and cost effective clinical operations

Shalom Kalnicki, M.D., F.A.C.R.O, Professor and Chairman, Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, NY

• Meeting the challenges of oncology care including: increased demand for services, staff and high-priced technologies

David Cheng, MD, PhD, Clinical Chief, Nuclear Medicine, YaleNew Haven Hospital / Yale Cancer Committee, CT

• Providing timely and cost effective treatment through advanced combined multiple imaging technologies including: PET/CT scanner

Sarah C. Lilly, MD, Integrative Medicine, Memorial SloanKettering Cancer Center, NY

• Emerging trends and the impact of technology on your oncology program: advancements in early detection, PET/CT, molecular imaging, image guided radiation therapy, proton therapy, chemotherapy and more

Joanne MacIsaac, Principal/Vice President, Interior Design, TRO/ The Ritchie Organization

• Successfully marketing your oncology services to the community to increase patient recruitment, revenue, and competitive advantage • Developing hospital partnerships to increase patient access to clinical trials, services and best practices • Structuring multi-disciplinary teams to increase patient focus, provide comprehensive treatment options and improve outcomes • Designing a patient friendly cancer center to accommodate increased staff, services, and future growth • Implementing outpatient service programs to increase patient convenience, satisfaction and quality of life

IN ASSOCIATION WITH:

Laura Baynham-Fletcher, MA, LPC, Director, Place of wellness, Integrative Medicine Program, The University of Texas, M. D. Anderson Cancer Center, TX Lennie Sender, MD, Deputy Clinical Director, UCI Chao Family Comprehensive Cancer Center (UC Irvine) Ira Goodman, Associate Director for Administration, Rebecca and John Moores University of California, San Diego (UCSD) Cancer Center Peg OʼGrady, RN, MSN, OCN, Director of Care Management and Operations, Fox Chase Cancer Center, Fox Chase Network Division, PA Ogan Gurel, MD MPHIL, CEO, Duravest, Inc., and Chairman, Aesis Research Group LLC Adjunct Professor, Roosevelt University Nina J. Pickett, M.H.A. Administrator Department of Pediatrics Memorial Sloan-Kettering Cancer Center James May, AIA Director of Operations Granary Associates

Adding, Updating and Expanding

COMPREHENSIVE CANCER PROGRAMS AND SERVICES For Hospitals and Health Systems PRE-CONFERENCE WORKSHOP: SEPTEMBER 18, 2006 2:00 PM – 4:00 PM

HOSPITAL-BASED VERSUS COMMUNITY-BASED CANCER CENTERS: HOW MEDICARE REIMBURSEMENT CHANGES THEIR RELATIONSHIPS

• The Changing Face of Part A Versus Part B Medicare Reimbursement in Oncology • Trends in Drug Payment • Trends in Protocol Payment for Common Regimens • Cognitive Payment and Its Importance • Why Community Practices Are Sending Hospitals Their Patients • Why Community Practices Might Want to Sell You Their Clinic: Should You Buy? • Conclusion: Is this The War On Cancer Patients? Roberta L. Buell is a Principal in Sausalito Healthcare Partners and a consultant in Oncology Reimbursement

DAY 1: SEPTEMBER 19, 2006 7:20 AM 7:50 AM

REGISTRATION, CONTINENTAL BREAKFAST AND EXHIBITS CHAIRPERSON’S WELCOMING REMARKS

Ogan Gurel, MD MPHIL CEO, Duravest, Inc., and Chairman, Aesis Research Group LLC Adjunct Professor, Roosevelt University

8:00 AM

DELIVERING MULTIDISCIPLINARY THERAPY FOR GI CANCER PATIENTS: CASE STUDY OF IMAGE –GUIDED RADIOTHERAPY TO BETTER TARGET TUMORS

This presentation focus on the use of novel imaging and radiotherapy delivery techniques to allow for more targeted therapy of upper GI tumors and are allowing for new attempts to dose escalate radiotherapy. • The treatment of gastrointestinal cancers requires a multidisciplinary approach, combining the care of medical oncologists, radiation oncologists, surgeons, and oncology nurses. • Many upper GI cancers, including pancreas and esophageal tumors have not responded well to conventional treatments. • Newer imaging radiation therapy delivery techniques may allow for better targeting of tumors and use of higher radiotherapy doses with the goal of improving local control of upper GI tumors. Karyn A. Goodman, M.D., Assistant Professor, Department of Radiation Oncology, Stanford Cancer Center

9:00 AM

EMERGING TECHNOLOGY TRENDS IMPACTING CANCER CARE

• New technologies on the horizon • Outlining the impact on both inpatient and outpatient oncology programs • Operational and Financial strategies for preparing for these technology changes Ogan Gurel, MD MPHIL CEO, Duravest, Inc., and Chairman, Aesis Research Group LLC Adjunct Professor, Roosevelt University

10:00 AM

MORNING REFRESHMENT BREAK

Adding, Updating and Expanding

COMPREHENSIVE CANCER PROGRAMS AND SERVICES For Hospitals and Health Systems 10:30 AM

THE ROLE OF INNOVATIVE RADIATION TECHNOLOGIES IN THE MODERN ACADEMIC CANCER CENTER

This presentation will address new modalities in radiation oncology and their applications in clinical trials, multidisiciplinary cancer management and academic cancer program development. The future directions for radiation oncology will be discussed. Additionally, the role of translational research, targeted therapies and laboratory advances in radiation technologies will be addressed. Attendees will learn how to: • Understand new radiation technology deployment in academic settings • Review translational research programs as they relate to radiation oncology • Plan for future radiation oncology program development in an integrated cancer center model Shalom Kalnicki, M.D., F.A.C.R.O, Professor and Chairman, Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, NY

11:30 AM

HOW INTEGRATIVE MEDICINE ENHANCES CANCER CARE

Dr. Lilly will present the principles of integrative oncology, discuss effective complementary therapies and botanicals, and comment on the collaboration between oncologists and integrative medicine experts in the research and clinical arena. The model of the Memorial Sloan-Kettering Cancer Center Department of Integrative Medicine will be described. Attendees will learn how to: • Understand and define integrative oncology, complementary medicine and alternative medicince • Learn the complementary therapies that benefit patients including acupuncture, massage, meditation, nutrition and fitness • Understand how the MSKCC Program of Integrative Medicine enhances care of patients with cancer and is part of an effective team approach to cancer care. Sarah C. Lilly, MD, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, NY

12:30 PM

CONFERENCE NETWORKING LUNCHEON

Lunchtime Presenter: Michael Saracen, Director, Product Marketing, Accuray Incorporated Robotic Radiosurgery: Complementing Existing Radiation Therapy, IMRT Or IGRT programs The CyberKnife Robotic Radiosurgery System is the worldʼs first and only radiosurgery system that utilizes intelligent robotics to treat tumors anywhere in the body with sub-millimeter accuracy. The CyberKnife System treats patients in single or staged (typically 2-5) sessions by delivering multiple beams of precisely directed radiation that converge upon the tumor while minimizing injury to surrounding healthy tissue. By enabling the treatment of extracranial tumors anywhere in the body that cannot be addressed with traditional radiosurgery or radiation therapy systems, Robotic Radiosurgery attracts a new patient population to physiciansʼ practices and complements existing radiation therapy, IMRT or IGRT programs.

1:45 PM

THE ROLE OF INTEGRATIVE MEDICINE IN COMPREHENSIVE CANCER CARE: BEST PRACTICES AND CHALLENGES

Ms. Baynham-Fletcher will present the three components of a comprehensive integrative medicine program and discuss best practices and challenges in establishing a program with a focus on clinical delivery. Topics will include credentialing, documentation, and quality assurance/outcome measures. The model of The University of Texas M. D. Anderson Cancer Centerʼs Integrative Medicine Program will be described. Attendees will learn how to: • Understand the three components of an integrative medicine program. • Discuss several best practices and challenges in the areas of credentialing, documentation, quality assurance/participant satisfaction and outcomes, marketing, and funding in an integrative medicine clinic. • Understand how the three components of UTMDACCʼs Integrative Medicine Program work collaboratively to create programs to manage side effects and enhance quality of life for cancer patients; provide educational resources for patients, public, and healthcare providers; and establish cutting-edge research as part of an effective approach to cancer care. Laura Baynham-Fletcher, MA, LPC, Director, Place of wellness, Integrative Medicine Program, The University of Texas, M. D. Anderson Cancer Center, TX

Adding, Updating and Expanding

COMPREHENSIVE CANCER PROGRAMS AND SERVICES For Hospitals and Health Systems 2:45 PM

CREATING A MULTI USE CANCER CENTER BUILDING

UCSD had planned for a multi use cancer center building for over 20 years. In the late 1990ʼs the plan reached fruition with the commitment incorporated in the Cancer Centerʼs NCI core grant application. The presentation translates the commitment to a building into a reality. The presentation will discuss the program and financial planning and construction of a 270,000 sf clinic and research building during the period 2001- 2005, the opening date of the building. It will cover the building objectives, financing, design, space allocation methodology and combined hospital/medical school cultures. It will summarize the lessons learned. Attendees will learn how to: • Assemble a financial plan for a building • Identify key building elements • Assign research space • Confront major logistical and cultural issues in creating a single hospital/ medical school building Ira Goodman, Associate Director for Administration, Rebecca and John Moores University of California, San Diego (UCSD) Cancer Center

3:45 PM 4:00 PM

AFTERNOON REFRESHMENT BREAK PANEL: COMPREHENSIVE CANCER CENTERS: OBSTACLES TO A SUCCESSFUL BUSINESS MODEL

Sarah C. Lilly, MD Ira Goodman, Associate Director for Administration Laura Baynham-Fletcher, MA, LPC, Director

4:45 PM

CHAIRPERSON’S CLOSING REMARKS, Q&A AND GENERAL QUESTIONS

Ogan Gurel, MD MPHIL CEO, Duravest, Inc., and Chairman, Aesis Research Group LLC Adjunct Professor, Roosevelt University

5:00 PM – 6:00 PM

STANFORD COMPREHENSIVE CANCER CENTER TOUR

DAY 2: SEPTEMBER 20, 2006 8:20 AM 8:55 AM

CONTINENTIAL BREAKFAST AND EXHIBITS CHAIRPERSON’S OPENING REMARKS

Ogan Gurel, MD MPHIL CEO, Duravest, Inc., and Chairman, Aesis Research Group LLC Adjunct Professor, Roosevelt University

9:00 AM

MULTI-DISCIPLINARY DISEASE MANAGEMENT PROGRAMS: HOW TO GROW REFERRALS AND RESEARCH

Due to the chronic nature of cancer care, institutions are struggling to develop best practices and streamlined patient care coordination. Multi-disciplinary disease programs foster collaborative treatment design but also offer an individualized plan of care to the patient. Fox Chase Network, a subsidiary corporation of Fox Chase Cancer Center, has assisted numerous community partners in Pennsylvania and New Jersey to assess, plan and implement disease management programs in the areas of breast, colon, lung and genitourinary cancers utilizing a multi-disciplinary team of experts at the community hospital site and a Nurse Navigator as a coordinator for patient care. By developing these disease teams, patients receive individual messaging regarding their disease specific needs (treatment options) as well as research initiatives they can participate in and benefit from. Breast Cancer Nurse Navigators are trained at Fox Chase Cancer Center quarterly on such topics as research, quality improvement, policy and procedure development, education tools, utilization of National Comprehensive Cancer Network guidelines for care and other best practice, evidence based methodologies. This Network partnership provides outreach of research and best practice yielding increased patient volumes in these multidisciplinary programs. Attendees will learn: • Verbalize an understanding of solid tumor multi-disciplinary programs in cancer product lines.

Adding, Updating and Expanding

COMPREHENSIVE CANCER PROGRAMS AND SERVICES For Hospitals and Health Systems • Describe the Nurse Navigator role in disease management development. • Define how the multidisciplinary program process contributes to the referral and research growth at community and comprehensive cancer centers. Peg OʼGrady, RN, MSN, OCN, Director of Care Management and Operations, Fox Chase Cancer Center, Fox Chase Network Division, PA

10:00 AM

THE ROLE OF NUCLEAR MEDICINE IN MANAGEMENT OF ONCOLOGY PATIENTS

Dr. Cheng will give an overview of the field of nuclear medicine in relation to oncology patients, including diagnostic, staging, and treatments. Attendees will learn how to: • What is Nuclear Medicine • What is the diagnostic role of Nuclear Medicine for oncology patients • What is the therapeutic role of Nuclear Medicine for oncology patients David Cheng, MD, PhD, Clinical Chief, Nuclear Medicine, Yale-New Haven Hospital / Yale Cancer Committee, CT

11:00 AM 11:30 AM

MORNING REFRESHMENT BREAK DESIGNING A PATIENT AND FAMILY FOCUSED CANCER CENTER WHILE MANAGING FUTURE GROWTH

• A case study from the Department of Pediatric Oncology at Memorial Sloan-Kettering Cancer Center • Data and strategies shared will be applicable for all types of cancer centers. • This informative session will address ways to successfully market oncology services to the community with a focus on improving competitive advantage, branding, patient recruitment and revenue. Nina J. Pickett, M.H.A. Administrator Department of Pediatrics Memorial Sloan-Kettering Cancer Center James May, AIA Director of Operations Granary Associates

12:30 PM

CONFERENCE NETWORKING LUNCHEON

Lunchtime Presenter: Corey Zankowski, PhD, Sr Director of Software Systems Marketing, Varian Medical Systems Managing oncology information in an integrated department • clinical drivers • operational efficiencies • connectivity from the enterprise to the devices • as an enabler for new capabilities

1:30 PM

SUCCESSFULLY IMPLEMENTING NEW AND COST EFFECTIVE ADOLESCENT AND YOUNG ADULT CANCER SERVICES

An overview of the special multi-disciplinary team approach needed for patients 0 to 30 years of age that are too old to be treated with pediatric regimens and too young to be treated with adult regimens. Lennie Sender, MD, Deputy Clinical Director, UCI Chao Family Comprehensive Cancer Center (UC Irvine)

2:30 PM

SUSTAINABILITY, PATIENT BUILDINGS AND THE ENVIRONMENT

Case study of 50,000 square foot LEED Silver-certified freestanding comprehensive cancer center in Augusta, Maine Attendees will learn how to: • Consolidation of two separate programs and how the process can be used as an opportunity for collaboration • Exploration of best practices of other services industries and how to use them as a catalyst for change • Master planning of a Greenfield site, allowing for further growth, with cancer center as the first phases • How a LEED-certification can provide enhanced marketability Joanne MacIsaac, Principal/Vice President, Interior Design, TRO/The Ritchie Organization

Adding, Updating and Expanding

COMPREHENSIVE CANCER PROGRAMS AND SERVICES For Hospitals and Health Systems 3:30 PM CHAIRPERSON’S CLOSING REMARKS, Q&A AND GENERAL QUESTIONS Ogan Gurel, MD MPHIL CEO, Duravest, Inc., and Chairman, Aesis Research Group LLC Adjunct Professor, Roosevelt University

3:40 PM END OF CONFERENCE Dear Healthcare Executive: The prognosis for cancer centers has improved with business diversification, financial restructuring and reorganization of resources. These paradigm shifts have strategically placed oncology center programs and services at the forefront of consumer preferences. Oncology is the number one service for which patients will travel and pay a premium to attain exceptional care. Due to the dynamic nature of the oncology community, continuing professional development for healthcare providers is not only necessary but essential. ACI will bring together leading hospital executives, physicians, nurse administrators and individuals involved in the care of cancer patients. The two-day symposium will focus on developing and effectively managing more competitive and comprehensive hospital cancer programs and adding or expanding oncology services to better detect, diagnose and treat cancer. Procure knowledge of case studies, research findings and successful organizational models from leading national oncology programs. Conference presenters from various sectors of the field will share their best practice models and comprehensive analysis of current programs and services. Register today for this unique networking and informational opportunity to develop tools and maximize the potential of your cancer center.

WHO WILL ATTEND The conference is ideally suited for physicians, nurses, administrators and other health professionals involved in the care of cancer patients – Representing Community Hospitals, Health Systems, Academic Medical Centers, Hospital Networks, Medical Laboratories and Comprehensive Cancer Centers. Director of Oncology Services. The conference is also well suited for physician leaders managing departments of: Medical Oncology, Clinical Oncology, Radiation Oncology, Multidisciplinary Oncology, Surgical Oncology and other specialized areas of oncology.

CONFERENCE VENUE TBD

HOTEL & AIRFARE TBD For special rates, call United Airlines at 1-800-521-4041 and mention ID code 556FA for discounted airfares. Take advantage of Special Conference Rates!

CONFERENCE FEES AND REGISTRATION Conference Fee: $1,995* Conference Documentation CD: $615 Conference+Workshop: $2,390* (Documentation CD includes copies of all proceedings on CD and shipping is included)

REGISTER 3 & GET 1 FREE! Any organization registering three persons at the same time will be entitled to a fourth registrant FREE of charge! For larger groups call (414) 221 1700 PAYMENT: ACI must recieve payment 5 days after receiving booking form.